Sodium Stibogluconate With Interferon Alpha-2b for Patients With Advanced Malignancies

This study has been completed.
Sponsor:
Collaborator:
VioQuest Pharmaceuticals
Information provided by (Responsible Party):
M.D. Anderson Cancer Center
ClinicalTrials.gov Identifier:
NCT00629200
First received: February 25, 2008
Last updated: November 21, 2011
Last verified: November 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2010
  Primary Completion Date: February 2010 (Final data collection date for primary outcome measure)